CA2441654A1 - Cytoskeleton-associated proteins - Google Patents

Cytoskeleton-associated proteins Download PDF

Info

Publication number
CA2441654A1
CA2441654A1 CA002441654A CA2441654A CA2441654A1 CA 2441654 A1 CA2441654 A1 CA 2441654A1 CA 002441654 A CA002441654 A CA 002441654A CA 2441654 A CA2441654 A CA 2441654A CA 2441654 A1 CA2441654 A1 CA 2441654A1
Authority
CA
Canada
Prior art keywords
polynucleotide
seq
polypeptide
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002441654A
Other languages
English (en)
French (fr)
Inventor
April J. A. Hafalia
Y. Tom Tang
Henry Yue
Farrah A. Khan
Craig H. Ison
Mariahy R. Baughn
Bridget A. Warren
Brendan M. Duggan
Kavitha Thangavelu
Cynthia D. Honchell
Yalda Azimzai
Vicki S. Elliott
Neil Burford
Li Ding
Huibin Yue
Shanya Becha
Brooke M. Emerling
Thomas W. Richardson
Soo Yeun Lee
Olga Bandman
Preeti G. Lal
Sally Lee
Kimberly J. Gietzen
Narinder K. Chawla
Jennifer A. Griffin
Ernestine A. Lee
Anita Swarnakar
Huijun Z. Ring
Karen Anne Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of CA2441654A1 publication Critical patent/CA2441654A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
CA002441654A 2001-03-29 2002-03-25 Cytoskeleton-associated proteins Abandoned CA2441654A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US28050801P 2001-03-29 2001-03-29
US60/280,508 2001-03-29
US28132301P 2001-04-03 2001-04-03
US60/281,323 2001-04-03
US28376901P 2001-04-13 2001-04-13
US60/283,769 2001-04-13
US28860901P 2001-05-04 2001-05-04
US60/288,609 2001-05-04
US29051801P 2001-05-10 2001-05-10
US60/290,518 2001-05-10
US29187001P 2001-05-18 2001-05-18
US60/291,870 2001-05-18
US29445101P 2001-05-29 2001-05-29
US60/294,451 2001-05-29
PCT/US2002/009288 WO2002079404A2 (en) 2001-03-29 2002-03-25 Cytoskeleton-associated proteins

Publications (1)

Publication Number Publication Date
CA2441654A1 true CA2441654A1 (en) 2002-10-10

Family

ID=27569565

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002441654A Abandoned CA2441654A1 (en) 2001-03-29 2002-03-25 Cytoskeleton-associated proteins

Country Status (5)

Country Link
EP (1) EP1373306A4 (de)
JP (1) JP2004533227A (de)
AU (1) AU2002306879A1 (de)
CA (1) CA2441654A1 (de)
WO (1) WO2002079404A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1402031A2 (de) 2001-06-21 2004-03-31 Isis Innovation Limited 'ange' gen in atopie
AU2003228872A1 (en) * 2002-05-10 2003-11-11 Incyte Corporation Cell adhesion and extracellular matrix proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017355A2 (en) * 1998-09-18 2000-03-30 Incyte Pharmaceuticals, Inc. Human cytoskeleton associated proteins
EP1171585A1 (de) * 1999-03-23 2002-01-16 Human Genome Sciences, Inc. 49 menschliche, ausgeschiedene proteine
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof

Also Published As

Publication number Publication date
AU2002306879A1 (en) 2002-10-15
EP1373306A4 (de) 2005-07-20
EP1373306A2 (de) 2004-01-02
WO2002079404A2 (en) 2002-10-10
JP2004533227A (ja) 2004-11-04
WO2002079404A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
CA2415808A1 (en) Transporters and ion channels
JP2004528003A (ja) 細胞外マトリクスおよび細胞接着分子
CA2417587A1 (en) Transporters and ion channels
JP2004531213A (ja) 輸送体及びイオンチャネル
CA2379968A1 (en) Gtp-binding protein associated factors
JP2004537254A (ja) 輸送体及びイオンチャネル
CA2410084A1 (en) Transporters and ion channels
CA2401113A1 (en) Transporters and ion channels
CA2443897A1 (en) Transporters and ion channels
WO2002101009A2 (en) Structural and cytoskeleton-associated proteins
JP2004537283A (ja) 輸送体及びイオンチャネル
CA2404229A1 (en) Human transporters and ion channels
CA2384324A1 (en) Proteins associated with cell differentiation
WO2002053719A2 (en) Cytoskeleton-associated proteins
CA2441654A1 (en) Cytoskeleton-associated proteins
CA2426939A1 (en) Cystoskeleton-associated proteins
US20040116670A1 (en) Cytoskeleton-associated proteins
US20040101884A1 (en) Molecules for disease detection and treatment
JP2004528002A (ja) 分泌分子および輸送分子
JP2004516007A (ja) 輸送体及びイオンチャネル
WO2002078420A2 (en) Molecules for disease detection and treatment
EP1451212A2 (de) Strukturproteine und mit dem cytoskelett assoziierte proteine
WO2003008625A2 (en) Structural and cytoskeleton-associated proteins
CA2436470A1 (en) Intracellular signaling molecules
CA2422497A1 (en) Transporters and ion channels

Legal Events

Date Code Title Description
FZDE Dead